Clinical Trial

Electroacupuncture and Exercise for Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Study acronym: EA-EX CIPN
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer treatment that causes numbness, pain, and balance issues in a patient's hands and feet. This study focuses on finding a non-drug approach to help cancer survivors manage these uncomfortable symptoms. The main purpose of this research is to evaluate whether combining Electroacupuncture(EA) with a exercise training program works better than using electroacupuncture alone. Electroacupuncture uses gentle electrical pulses through acupuncture needles to stimulate nerves, while the exercise program aims to improve a patient's balance, physical strength, and movement safety. Participants will be randomly assigned to receive either the combination therapy or electroacupuncture alone. The study involves scheduled hospital visits along with home-based practice guided by instructional videos. The researchers aim to evaluate the efficacy of combined EA and exercise training program on neurological symptoms and quality of life in CIPN patients across different CTCAE grades.
Trial Details
NCT Number NCT07700901
Lead Sponsor Show Chwan Memorial Hospital
Conditions Cancer, Chemotherapy-induced Peripheral Neuropathy (CIPN)
Enrollment 82 participants
Start Date 2026-07-15
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-14